CLS-Logo-1.jpg
CLS Exhibits MRI-Guided, Focal Laser Ablation System for Prostate Cancer at the 94th National Congress of the Italian Society of Urology
October 15, 2021 04:00 ET | Clinical Laserthermia Systems Americas, Inc.
RICCIONE, Italy, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today announced it will present its high precision, image-guided TRANBERG® Laser Thermal Therapy...
Tricol Biomedical Receives NIH Phase IIB Grant to Continue Development of its Hemostatic Device for the Prostate
October 07, 2021 11:00 ET | Tricol Biomedical
Portland, OR, Oct. 07, 2021 (GLOBE NEWSWIRE) -- Tricol Biomedical, a privately held medical device company dedicated to saving lives through innovative hemostatic and wound care solutions, has...
The Inaugural Distinguished Gentleman's Drive Unites Thousands of Stylish Classic Car Drivers Around the World in Its First-Ever Charity Drive
September 28, 2021 19:36 ET | The Distinguished Gentleman's Drive
SYDNEY, Sept. 29, 2021 (GLOBE NEWSWIRE) -- On Sunday, Sept. 26, 2021, thousands of dapper drivers took part in the world's largest and most stylish vintage automotive event. The first event of its...
22157.jpg
Global Cancer Biopsy Market Analysis Report 2021: Advent of Liquid Biopsy & Transition of Novel Oncology Diagnostics from Bench to Clinics - Forecast to 2027
September 20, 2021 04:43 ET | Research and Markets
Dublin, Sept. 20, 2021 (GLOBE NEWSWIRE) -- The "Global Cancer Biopsy Market Size, Share & Trends Analysis Report 2021-2027" report has been added to ResearchAndMarkets.com's offering. The global...
CLS-Logo-1.jpg
CLS Exhibits High Precision, Image-Guided Focal Laser Ablation System at the 73rd Congress of the German Society for Urology Conference
September 14, 2021 03:00 ET | Clinical Laserthermia Systems Americas, Inc.
STUTTGART, Germany, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today announced it will present its high precision, image-guided TRANBERG® Laser Thermal Therapy...
AB Science announced today that results from masitinib study AB12003 in prostate cancer have been presented at the 2021 American Urological Association
September 13, 2021 12:04 ET | AB Science
PRESS RELEASE RESULTS FROM MASITINIB STUDY AB12003 IN PROSTATE CANCER PRESENTED AT THE AMERICAN UROLOGICAL ASSOCIATION ANNUAL MEETING WITH ABSTRACT PUBLISHED IN JOURNAL OF UROLOGY Paris, 13...
AB Science annonce que les résultats de l'étude AB12003 du masitinib dans le cancer de la prostate ont été présentés lors du congrès annuel 2021 de l'American Urological Association
September 13, 2021 12:04 ET | AB Science
COMMUNIQUE DE PRESSE LES RESULTATS DE L’ETUDE AB12003 DU MASITINIB DANS LE CANCER DE LA PROSTATE ONT ETE PRESENTES LORS DU CONGRES ANNUEL DE L’AMERICAN UROLOGICAL ASSOCIATION ET ONT ETE PUBLIES DANS...
20170406 Telix Logo.png
Telix and Radius Sign Italian Distribution Agreement for Prostate Cancer Imaging
September 12, 2021 18:36 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and BOLOGNA, Italy, Sept. 13, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that it has entered into an exclusive...
20170406 Telix Logo.png
Japanese Prostate Cancer Imaging Study Completes Enrolment
September 08, 2021 18:57 ET | Telix Pharmaceuticals Limited
MELBOURNE, Australia and KYOTO, Japan, Sept. 08, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the last patient has been imaged in a...
arvinas_logoART_lg.jpg
Arvinas to Participate in Upcoming Virtual Investor Conferences
September 01, 2021 07:00 ET | Arvinas Inc.
NEW HAVEN, Conn., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation, today...